Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemiaDeepa Bhojwani, Susan R. Rheingold, Constance M. Yuan et al.|Leukemia|2018Cited by 209
Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemiaCornelis M. van Tilburg, Olaf Witt, Till Milde et al.|Clinical Epigenetics|2019Cited by 44